Status:
COMPLETED
Rotigaptide in Endothelial Dysfunction?
Lead Sponsor:
University of Edinburgh
Collaborating Sponsors:
University of Aarhus
University of Oxford
Conditions:
Ischaemic Heart Diseases
Eligibility:
MALE
18-65 years
Phase:
NA
Brief Summary
Arterial occlusion can lead to tissue ischemia and, if prolonged, end organ infarction. Clinical and experimental data would suggest that restoration of blood flow might trigger additional injury beyo...
Eligibility Criteria
Inclusion
- healthy males between 18-65 years of ages, non-smokers.
Exclusion
- Any concurrent illness or chronic medical condition. Concurrent use of vasoactive medication. Smoking history.
Key Trial Info
Start Date :
September 19 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2009
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT07192744
Start Date
September 19 2008
End Date
December 31 2009
Last Update
September 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Edinburgh, 49 Little France Crescent
Edinburgh, United Kingdom, EH16 4SB